Research
Molecular
The compounds K2 and K5 modify CCK1 activity by preventing/hindering interactions between CCK peptides and CCK1.
Understanding how K2 and K5 interact with CCK1 can guide drug development.
StrongSupportsmedium confidence
likely by preventing/hindering interactions between CCK peptides and CCK1, modifying its activity.
Why this rating
Based on study design from abstract.
Source
Compounds Interacting with Cholecystokinin as Potential Drugs Against Excessive Weight Gain and Obesity
José Luis Vique‐Sánchez et al. · ChemistrySelect · 2023
otherCited 3×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →